Urologist Adam J. Gadzinski, MD, MS, shares his excitement about the dawn of the precision medicine era in prostate cancer.
In this video, Adam J. Gadzinski, MD, MS, highlights how precision medicine in prostate cancer was a key topic at the 2020 Society of Urologic Oncology Annual Meeting and marks the next great leap forward in the field. Gadzinski is an acting instructor of urologic oncology at the Urology Clinic at the University of Washington Medical Center.
Treatment intensification in advanced prostate cancer: Real-world practice lags behind data
June 9th 2023"It gives me a very rewarding experience…. I see patients with low-grade prostate cancer and when they become advanced prostate cancer, I already have a good relationship with them and don’t have to send them somewhere else," says Abhinav Sidana, MD, MPH.
Emulating target trials using observational evidence to inform clinical decision-making
June 2nd 2023"The emulation framework lends the design and conduct of observational analyses some of the rigor required for the planning of a randomized trial. In doing so, it provides an innovative and principled approach to improve the evidence base on the comparative effectiveness of interventions," writes Boris Gershman, MD, and Aaron Fleishman, MPH.
2 Clarke Drive
Cranbury, NJ 08512